Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities PRPH - ProPhase Labs, Inc.
-1.37 M
LAST VALUE
73.62%
2 YEAR CAGR
-2.21%
5 YEAR CAGR
-11.97%
10 YEAR CAGR